tumor agnostic drugs

FDA reviews Merck & Co’s Keytruda in new ‘tumour agnostic’ use
Pharmaforum
Wed, 04/8/20 - 10:55 am
Merck
Keytruda
tumor agnostic drugs
biomarkers
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Pharmaforum
Tue, 09/24/19 - 09:28 am
Bayer
TRK inhibitors
Vitrakvi
Europe
tumor agnostic drugs
cancer